Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoru Mitsuboshi

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Journal of Clinical Pharmacology|July 29, 2023
Reply to: Comment: Detection of Vaccine Adverse Events Before Package Insert Revisions Using a Japanese Spontaneous Reporting SystemShimon Suzuki, Shungo Imai, Satoru Mitsuboshi, et al.
Basic & Clinical Pharmacology & Toxicology|February 17, 2022
Atenolol and mortality events in patients with chronic kidney disease: Analysis of data from the Japanese Adverse Drug Event Report databaseSatoru Mitsuboshi, Takahiro Niimura, Fuka Aizawa, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 3, 2020
[Is Concomitant Therapy with Acetaminophen and Low-dose Aspirin a Risk Factor for CKD Progression? A 6-Year Cohort Study]Satoru Mitsuboshi, Hitoshi Yamada, Shuji Yamazaki, et al.
Clinical and Experimental Nephrology|January 12, 2026
Validation of diagnostic coding for chronic kidney disease using a Japanese hospital-based databaseMomiji Otani-Kono, Shungo Imai, Masami Tsuchiya, et al.
Japanese Journal of Infectious Diseases|November 2, 2018
Does Quick Sepsis-Related Organ Failure Assessment Suggest the Use of Initial Empirical Carbapenem Therapy in Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Bacteria? :A Multicenter Case-Control StudySatoru Mitsuboshi, Naoki Tsuruma, Kazuya Watanabe, et al.
British Journal of Clinical Pharmacology|November 22, 2023
Influence of vasopressin receptor antagonists on triple-whammy acute kidney injury: A VigiBase analysisSatoru Mitsuboshi, Kenji Hayakawa, Hirofumi Hamano, et al.
Japanese Journal of Infectious Diseases|November 2, 2020
Does Quinolone- or Macrolide-Resistant Streptococcus agalactiae Bacteremia Affect Patient Outcome? A Multicenter Cohort StudySatoru Mitsuboshi, Junichiro Date, Naoki Tsuruma, et al.
Japanese Journal of Infectious Diseases|March 3, 2020
Advanced Age is not a Risk Factor for Mortality in Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Organisms: a Multicenter Cohort StudySatoru Mitsuboshi, Naoki Tsuruma, Kazuya Watanabe, et al.
European Journal of Clinical Pharmacology|November 23, 2024
Association between sodium-glucose cotransporter-2 inhibitor and adverse events in patients with moderate to severe chronic kidney disease: a systematic review and meta-analysis of randomized controlled trialsSatoru Mitsuboshi, Kotaro Hitoshi, Ai Ominato, et al.
The Annals of Pharmacotherapy|February 27, 2023
Proton Pump Inhibitors and Rhabdomyolysis: Analysis of Two Different Cross-Sectional DatabasesSatoru Mitsuboshi, Hirofumi Hamano, Yurika Kuniki, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Journal of Clinical Pharmacology|July 29, 2023
Reply to: Comment: Detection of Vaccine Adverse Events Before Package Insert Revisions Using a Japanese Spontaneous Reporting SystemShimon Suzuki, Shungo Imai, Satoru Mitsuboshi, et al.
Basic & Clinical Pharmacology & Toxicology|February 17, 2022
Atenolol and mortality events in patients with chronic kidney disease: Analysis of data from the Japanese Adverse Drug Event Report databaseSatoru Mitsuboshi, Takahiro Niimura, Fuka Aizawa, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 3, 2020
[Is Concomitant Therapy with Acetaminophen and Low-dose Aspirin a Risk Factor for CKD Progression? A 6-Year Cohort Study]Satoru Mitsuboshi, Hitoshi Yamada, Shuji Yamazaki, et al.
Clinical and Experimental Nephrology|January 12, 2026
Validation of diagnostic coding for chronic kidney disease using a Japanese hospital-based databaseMomiji Otani-Kono, Shungo Imai, Masami Tsuchiya, et al.
Japanese Journal of Infectious Diseases|November 2, 2018
Does Quick Sepsis-Related Organ Failure Assessment Suggest the Use of Initial Empirical Carbapenem Therapy in Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Bacteria? :A Multicenter Case-Control StudySatoru Mitsuboshi, Naoki Tsuruma, Kazuya Watanabe, et al.
British Journal of Clinical Pharmacology|November 22, 2023
Influence of vasopressin receptor antagonists on triple-whammy acute kidney injury: A VigiBase analysisSatoru Mitsuboshi, Kenji Hayakawa, Hirofumi Hamano, et al.
Japanese Journal of Infectious Diseases|November 2, 2020
Does Quinolone- or Macrolide-Resistant Streptococcus agalactiae Bacteremia Affect Patient Outcome? A Multicenter Cohort StudySatoru Mitsuboshi, Junichiro Date, Naoki Tsuruma, et al.
Japanese Journal of Infectious Diseases|March 3, 2020
Advanced Age is not a Risk Factor for Mortality in Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Organisms: a Multicenter Cohort StudySatoru Mitsuboshi, Naoki Tsuruma, Kazuya Watanabe, et al.
European Journal of Clinical Pharmacology|November 23, 2024
Association between sodium-glucose cotransporter-2 inhibitor and adverse events in patients with moderate to severe chronic kidney disease: a systematic review and meta-analysis of randomized controlled trialsSatoru Mitsuboshi, Kotaro Hitoshi, Ai Ominato, et al.
The Annals of Pharmacotherapy|February 27, 2023
Proton Pump Inhibitors and Rhabdomyolysis: Analysis of Two Different Cross-Sectional DatabasesSatoru Mitsuboshi, Hirofumi Hamano, Yurika Kuniki, et al.
Pageof 7